BB&T Securities’s Medicines Co MDCO Stock Holding History

BB&T Securities’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-30,674	Closed	-$1.14M	–	1529
2017 Q3	$1.14M	Buy	30,674 +1,498	+5%	+$55.2K	0.02%	703
2017 Q2	$1.11M	Buy	+29,176	New	+$1.3M	0.02%	701

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

TBC

Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB&T Securities's MDCO Position: Q4 2017 in Review

BB&T Securities sold out of Medicines Co (MDCO) in Q4 2017, closing a stake of 30,674 shares — an estimated $1.14M sold.

BB&T Securities first reported a position in MDCO in Q2 2017 and held it in 2 quarters. The position peaked at $1.14M in Q3 2017. 202 funds tracked by Wall St. Rank hold MDCO as of Q4 2017.

BB&T Securities reported no remaining Medicines Co position as of Q4 2017 after selling out during the quarter.
BB&T Securities sold 30,674 Medicines Co shares in Q4 2017, an estimated $1.14M.
BB&T Securities first reported a position in Medicines Co in Q2 2017 and held it in 2 quarters.
BB&T Securities's Medicines Co position peaked at $1.14M in Q3 2017.
202 funds tracked by Wall St. Rank held Medicines Co as of Q4 2017.

Based on BB&T Securities's 13F filing for Q4 2017, filed 15 Feb 2018.